Cryptogenic anti-8 inhibitor
Rochon, M.; Neemeh, J.A.; Gosselin, G.; Long, L.A.
L'Union Medicale du Canada 100(12): 2353-2356
1971
ISSN/ISBN: 0041-6959 PMID: 5163028 Document Number: 36992
Document emailed within 1 workday
Related Documents
Reyes, E.F.; Virgo, B.B. 1988: Neonatal programming of ethylmorphine demethylase and corticosteroid 5 alpha-reductase by testosterone, dihydrotestosterone, and estradiol. Effects of an anti-estrogen, an anti-androgen, and an inhibitor of estrogen synthetase Drug Metabolism and Disposition: the Biological Fate of Chemicals 16(1): 93-97Saratikov, A.S.; Iavorovskaia, V.E.; Luttseva, M.A.; Prishchep, T.P. 1976: Antiviral inhibitor induction under the influence of some anti-inflammatory agents Farmakologiia i Toksikologiia 39(2): 186-190
Khokha, R.; Denhardt, D.T. 1987: On the use of anti-sense RNA: down-regulation of mRNA encoding a metalloproteinase inhibitor Anticancer Research 7(4a): 653-660
Peng, Z-Gen.; Chen, H-Shan.; Wang, L.; Liu, G. 2008: Anti-HIV activities of HIV-1 reverse transcriptase inhibitor racemic 11-demethyl-calanolide A Yao Xue Xue Bao 43(5): 456-460
Bourinbaiar, A.S.; Lee-Huang, S. 1995: Acrosin inhibitor, 4'-acetamidophenyl 4-guanidinobenzoate, an experimental vaginal contraceptive with anti-HIV activity Contraception 51(5): 319-322
Pei, T.; Liu, F.; Deng, A.-p. 2016: Synthesis and anti-tumor activity of ciprofloxacin-histone deacetylase inhibitor conjugates Yao Xue Xue Bao 51(12): 1871-1880
Krasnikova, T.L.; Sidorova, M.V.; Aref'eva, T.I.; Kukhtina, N.B.; Az'muko, A.A.; Bespalova, Z.D. 2009: Development of a new anti-inflammatory peptide preparation--inhibitor of the monocytic chemotaxic protein-1 (MCP-1) Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 95(5): 494-506
Eisenlohr, J.J.; Gehlen, W. 1974: Long-term study on the anti-rigidity effect of L-dopa and a decarboxylase inhibitor (ro 8-0576) Münchener Medizinische Wochenschrift 116(28): 1353-1356
De Almagro, M.C.; Vucic, D. 2012: The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy Experimental Oncology 34(3): 200-211
McMahon, J.B.; Buckheit, R.W.; Gulakowski, R.J.; Currens, M.J.; Vistica, D.T.; Shoemaker, R.H.; Stinson, S.F.; Russell, J.D.; Bader, J.P.; Narayanan, V.L.; Schultz, R.J.; Brouwer, W.G.; Felauer, E.E.; Boyd, M.R. 1996: Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor Journal of Pharmacology and Experimental Therapeutics 276(1): 298-305
Sincholle, D.; Bertez, C.; Legrand, A.; Conduzorgues, J.P.; Bonne, C. 1985: Anti-inflammatory activity of a dual inhibitor of cyclooxygenase and lipoxygenase pathways, CBS-1108 (2-acetylthiophene-2-thiazolylhydrazone) Arzneimittel-Forschung 35(8): 1260-1263
Shuratov, I.K.; Kosiakov, P.N. 1975: Immunochemical characteristics of human blood proteins, exhibiting anti-influenza gamma-inhibitor activity Voprosy Virusologii 1: 42-47
Lutze, G.; Canzler, E.; Presser, H.J. 1989: Spontaneous post-partum inhibitor to factor VIIi clotting anti- gen--a cause of life-threatening hemorrhage Zentralblatt für Gynakologie 111(3): 167-172
Laurell, M.; Stenflo, J. 1989: Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein Thrombosis and Haemostasis 62(3): 885-891
Frankiewicz-Jóźko, A.; Grudziński, I.P. 2005: Effects of nitric oxide syntase inhibitor on exercise-mediated pro- and anti-oxidative balance in rat blood plasma Roczniki Panstwowego Zakladu Higieny 56(4): 339-345
Counillon, L.; Scholz, W.; Lang, H.J.; Pouysségur, J. 1993: Pharmacological characterization of stably transfected Na+/H+ antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties Molecular Pharmacology 44(5): 1041-1045
Kano, S. 1999: Serological diagnosis of streptococcal infection (anti-streptolysin O; ASO, anti-streptokinase; ASK, anti-deoxyribonuclease B; ADNB, anti-hyaluronidase; AHD, anti-streptococcal polysaccharide; ASP) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 107-116
Tamaki, H.; Amino, N.; Watanabe, Y.; Aozasa, M.; Iwatani, Y.; Miyai, K.; Kumahara, Y. 1985: Standardization of the radioreceptor assay for anti-thyrotropin receptor antibodies (thyrotropin-binding inhibitor immunoglobulin) Rinsho Byori. Japanese Journal of Clinical Pathology 33(9): 1015-1019
Kowaluk, E.A.; Mikusa, J.; Wismer, C.T.; Zhu, C.Z.; Schweitzer, E.; Lynch, J.J.; Lee, C.H.; Jiang, M.; Bhagwat, S.S.; Gomtsyan, A.; McKie, J.; Cox, B.F.; Polakowski, J.; Reinhart, G.; Williams, M.; Jarvis, M.F. 2000: ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. in vivo characterization in the rat Journal of Pharmacology and Experimental Therapeutics 295(3): 1165-1174
Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47